Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Critical Care Diagnostics Inc patents


Recent patent applications related to Critical Care Diagnostics Inc. Critical Care Diagnostics Inc is listed as an Agent/Assignee. Note: Critical Care Diagnostics Inc may have other listings under different names/spellings. We're not affiliated with Critical Care Diagnostics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Critical Care Diagnostics Inc-related inventors


Methods and systems for determining risk of heart failure

Provided are methods, algorithms, nomograms, and computer/software systems that can be used to accurately determine the risk of developing heart failure within a specific time period in a subject not diagnosed or presenting with heart failure. Also provided are methods, algorithms, nomograms, computer/software systems for selecting a treatment for a subject and determining the efficacy of a treatment for reducing the risk of heart failure in a subject.. ... Critical Care Diagnostics Inc

Methods for predicting risk of developing hypertension

Methods using biomarkers, e.g., serum levels of st2, to predict risk of developing hypertension, as well as methods for treating subjects to reduce the risk of developing hypertension and methods for selecting and/or stratifying subjects for clinical trials of treatments to reduce the risk of hypertension.. . ... Critical Care Diagnostics Inc

Multimarker risk stratification

Measurement of circulating st2 and natriuretic peptide (e.g., nt-probnp) concentrations is useful for the prognostic evaluation of subjects, in particular for the prediction of adverse clinical outcomes, e.g., mortality, transplantation, and heart failure.. . ... Critical Care Diagnostics Inc

Predicting mortality and detecting severe disease

Measurement of circulating st2 and/or il-33 concentrations is useful for the prognostic evaluation of subjects, in particular for the prediction of adverse clinical outcomes, e.g., mortality, and the detection of severe disease.. . ... Critical Care Diagnostics Inc

Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy

Methods of treating a subject having a cardiovascular disease, selecting a therapy for a subject having a cardiovascular disease, identifying a subject having a cardiovascular disease that will benefit or not benefit from exercise therapy, determining whether a subject having a cardiovascular disease should begin, continue, not begin, discontinue, or avoid exercise therapy, determining whether a subject having a cardiovascular disease should continue, discontinue, or avoid exercise therapy, reducing the risk of an adverse outcome (e.g., death) in a subject having a cardiovascular disease, and predicting the efficacy of exercise therapy in a subject having a cardiovascular disease. These methods include determining a level of soluble st2 in a subject.. ... Critical Care Diagnostics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Critical Care Diagnostics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Critical Care Diagnostics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###